Science Current Events | Science News | Brightsurf.com
 

Drug Resistant Disease Current Events | Drug Resistant Disease News | 8

Sort By: Page Views | Date

New medications show promise in treating drug-resistant prostate cancer
A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.   view more (2009-04-08)

Study of the drug, Isradipine, to determine if it slows or prevents Parkinson's disease
Gloria E. Meredith, Ph.D., collaborated with D. James Surmeier, Ph.D. and other scientists at Northwestern University to study the drug, Isradipine, and its possible effects on Parkinson's disease.   view more (2007-06-14)

Resistance to chemotherapy in lung cancer, optimizing flu vaccination strategies
Lung cancer is the most common cause of cancer-related death worldwide, in part because these tumors often are or become resistant to chemotherapy.   view more (2006-10-03)

Fresh Hopes For Treatment Of Malaria In Africa (p 1218)
Despite the large number of deaths caused worldwide by AIDS, tuberculosis, and diarrhoeal diseases such as cholera, the biggest infectious-disease killer is still malaria, especially in Africa. Efforts to eradicate the carrier of malaria, a mosquito, have been only partly successful. The standard treatment for malaria has, for many years, been... view more... (2001-10-10)

New Research Helps Explain the Rise in Hospital MRSA Infections
New research by scientists by the University of Warwick may explain why methicillin-resistant Staphylococcus aureus (MRSA) infections are so difficult to control in hospitals. MRSA is a major cause of invasive and sometimes deadly disease in hospitalised patients. Currently, attempts to prevent spread of these infections include isolating infected... view more... (2004-06-18)

The complexities of genetic susceptibility to tuberculosis revealed
Researchers working in Vietnam have identified a genetic variant that predisposes people to developing a lethal form of tuberculosis (TB), tuberculous meningitis, if they are infected with a strain of TB known as the Beijing strain.   view more (2008-03-28)

What are the characteristics of clarithromycin-resistant Helicobacter pylori?
Clarithromycin is currently one of the antibiotics used for eradication of Helicobacter pylori. However, reports of H. pylori resistance to this antibiotic are increasing worldwide.   view more (2009-07-16)

Ireland Cancer Center researchers advance lung cancer treatment
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.   view more (2007-04-24)

Typhoid fever cases in US linked to foreign travel
Infection with an antimicrobial-resistant strain of typhoid fever among patients in the United States is associated with international travel, especially to the Indian subcontinent (India, Pakistan, and Bangladesh).   view more (2009-08-26)

Research provides promising evidence of new drug therapies in lethal lung disease
Several promising new treatments may prolong lives as well as improve the quality of life for people living with pulmonary arterial hypertension.   view more (2006-04-07)

New cost-effective means to reconstruct virus populations
Researchers from the United States and Switzerland have developed mathematical and statistical tools for reconstructing viral populations using pyrosequencing, a novel and effective technique for sequencing DNA. They describe their findings in an article published May 9th in the open-access journal PLoS Computational Biology.   view more (2008-05-09)

Tamiflu survives sewage treatment
Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment.   view more (2007-10-03)

Herbicide diversity needed to keep Roundup effective
Using a diverse herbicide application strategy may increase production costs, but a five-year Purdue University study shows the practice will drastically reduce weeds and seeds that are resistant to a popular herbicide.    view more (2009-07-14)

Disease activity increases after MS patients stop drug
People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity.   view more (2007-09-13)

New approach could lower antibiotic requirements by 50 times
Antibiotic doses could be reduced by up to 50 times using a new approach based on bacteriophages.   view more (2007-01-29)

Sussex scientist makes MRSA treatment breakthrough with synthetic antibiotic
A groundbreaking new treatment to combat the hospital killer bug MRSA, which is estimated to cause up to 5,000 deaths a year in Britain, is being developed by a University of Sussex scientist.   view more (2005-02-22)

New approach could lower antibiotic requirements by 50 times
Steven Hagens, previously at the University of Vienna, told Chemistry & Industry, the magazine of the SCI, that certain bacteriophages, a type of virus that infects bacteria, can boost the effectiveness of antibiotics gentamicin, gramacidin or tetracycline.   view more (2007-01-30)

Four out of five head lice resistant to common treatment
Four out of five head lice are resistant to a common treatment used to eradicate them, finds a study of Welsh schoolchildren, published ahead of print in the Archives of Disease in Childhood.   view more (2006-06-14)

No disease in the desert
Camels are known for their amazing ability to survive in arid conditions, but new research shows that their immune response may also be helping them to stay strong. Their innate abilities could soon alter the way that human diseases are fought. Biologists are always on the lookout for new methods to combat disease. Camel antibodies show great... view more... (2001-12-04)

Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage.   view more (2009-09-22)
Sort By: Page Views | Date
© 2009 BrightSurf.com